KCM Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,615
Closed -$256K 548
2016
Q4
$256K Sell
10,615
-252
-2% -$7.01K 0.02% 476
2016
Q3
$302K Buy
10,867
+101
+0.9% +$2.67K 0.02% 440
2016
Q2
$263K Sell
10,766
-262
-2% -$7.43K 0.02% 449
2016
Q1
$370K Buy
11,028
+444
+4% +$14K 0.03% 386
2015
Q4
$316K Buy
10,584
+1,150
+12% +$38.8K 0.03% 401
2015
Q3
$297K Sell
9,434
-659
-7% -$32.2K 0.02% 413
2015
Q2
$488K Buy
10,093
+4,076
+68% +$172K 0.04% 354
2015
Q1
$261K Buy
+6,017
New +$216K 0.02% 456

Other funds holding PGEN

KCM Investment Advisors's PGEN Position: Q1 2017 in Review

KCM Investment Advisors sold out of Precigen (PGEN) in Q1 2017, closing a stake of 10,615 shares — an estimated $256K sold.

KCM Investment Advisors first reported a position in PGEN in Q1 2015 and held it in 8 quarters. The position peaked at $488K in Q2 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • KCM Investment Advisors reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • KCM Investment Advisors sold 10,615 Precigen shares in Q1 2017, an estimated $256K.
  • KCM Investment Advisors first reported a position in Precigen in Q1 2015 and held it in 8 quarters.
  • KCM Investment Advisors's Precigen position peaked at $488K in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on KCM Investment Advisors's 13F filing for Q1 2017, filed 15 May 2017.